Bevacizumab treatment led to increased expression and enzymatic activity of MMP-2 and MMP-9, common metalloproteinases associated with neovascularization of tumors, in glioblastoma cells both in vitro and in vivo [64,109]. This evidence concerns the gene MMP2 and glioblastoma.